PoliticalRepoPoliticalRepo

Subjects · European Union

Healthcare

Records whose title is actually about this topic. Use a country filter if the list is still too broad.

51 records in EU

All countriesUnited States · 37,046Ireland · 10,968Netherlands · 4,588United Kingdom · 1,134Germany · 1,105European Union · 713France · 35Search this topic

Records

Record· TJCELEX 62025TJ0430decided

Judgment of the General Court (Seventh Chamber) of 2 September 2026.#Christoph Klein v European Commission.#Non-contractual liability - Public health - Union legal framework for medical devices - Safeguard clause - Article 8(1) and (2) of Directive 93/42/EEC - Notification by a Member State of a decision prohibiting the placing on the market of a medical device - Continued failure of the Commission to act - Medical device 'Inhaler Broncho-Air®' - Repeal of Directive 93/42 - Articles 94 to 97 of Regulation (EU) 2017/745 - Article 41 of the Charter of Fundamental Rights - Actual and certain damage.#Case T-430/25.

European Union · Court of Justice of the European Union · 2 September 2026

Record· CJCELEX 62024CJ0427decided

Judgment of the Court (Sixth Chamber) of 2 July 2026.#Zentrale zur Bekämpfung unlauteren Wettbewerbs Frankfurt am Main eV v Diagramm Halbach GmbH & Co. KG.#Reference for a preliminary ruling – Medical devices – Regulation (EU) 2017/745 – Obligations of distributors before making a device available on the market – Identification wristbands intended to be worn by patients in the healthcare sector – No CE marking and no EU declaration of conformity – Concept of ‘medical device’ – Concept of ‘intended purpose’.#Case C-427/24.

European Union · Court of Justice of the European Union · 2 July 2026

Record· CJCELEX 62024CJ0604decided

Judgment of the Court (Fifth Chamber) of 21 May 2026.#FARMAKEIO YZ & SIA O.E. v Ypourgos Anaptyxis kai Ependyseon and Ypourgos Ygeias.#Reference for a preliminary ruling – Medicinal products for human use – Directive 2001/83/EC – Article 85c(1) and (2) – Non-prescription medicinal products – Prohibition of the sale at a distance to the public, by means of information society services, of a category of non-prescription medicinal products – Protection of public health.#Case C-604/24.

European Union · Court of Justice of the European Union · 21 May 2026

Record· CJCELEX 62024CJ0483decided

Judgment of the Court (Third Chamber) of 13 May 2026.#Criminal proceedings against Aldi SA.#Reference for a preliminary ruling – Public health – Food law – Regulation (EC) No 178/2002 – General principles and requirements – Regulation (EC) No 852/2004 – Food hygiene – Article 4(2) – General and specific obligations on all food business operators – Scope – Annex II – General provisions on hygiene for those operators – Article 5 – Hazard analysis and critical control points principles (HACCP principles) – Scope – Repeated finding, by the competent authority, of traces and droppings of pests in the shops and warehouses of an undertaking in the food sector – Criminal offence provided for in national law in implementation of the third subparagraph of Article 17(2) of Regulation No 178/2002.#Case C-483/24.

European Union · Court of Justice of the European Union · 13 May 2026

Record· CJCELEX 62024CJ0118decided

Judgment of the Court (Second Chamber) of 23 April 2026.#EG Labo Laboratoires Eurogenerics SAS and Theramex France SAS v Agence nationale de sécurité du médicament et des produits de santé (ANSM) and Biogaran SAS.#Request for a preliminary ruling from the Conseil d'État.#Reference for a preliminary ruling – Directive 2001/83/EC – Medicinal products for human use – Articles 28 and 29 – Decentralised procedure for marketing authorisation for a medicinal product – Article 10 – Generic medicinal product – Abridged procedure for granting a marketing authorisation – Biological medicinal product serving as reference medicinal product for a chemical medicinal product – Jurisdiction of the courts of the Member States concerned to determine whether there is a potential serious risk for public health – Jurisdiction of those courts to review the conditions for granting a marketing authorisation for a generic medicinal product.#Case C-118/24.

European Union · Court of Justice of the European Union · 23 April 2026

Record· CJCELEX 62024CJ0513decided

Judgment of the Court (Second Chamber) of 19 March 2026.#Oblastní nemocnice Kolín, a. s., nemocnice Středočeského kraje v Odvolací finanční ředitelství.#Request for a preliminary ruling from the Nejvyšší správní soud.#Reference for a preliminary ruling – Taxation – Common system of value added tax (VAT) – Directive 2006/112/EC – Right to deduct VAT – Article 173(1) – Proportional deduction – Expenditure forming part of the general costs of a taxable person – Minimum technical and material equipment of healthcare facilities required in order to obtain a licence to supply healthcare services in respect of which VAT is not deductible – Services necessary for the supply of services in respect of which VAT is deductible.#Case C-513/24.

European Union · Court of Justice of the European Union · 19 March 2026

Record· TOCELEX 62025TO0265_INFdecided

Order of the General Court (Ninth Chamber) of 27 February 2026.#IW v European Commission and European Medicines Agency.#Action for damages – Public health – Medicinal products for human use – Conditional marketing authorisation for the COVID-19 Vaccine AstraZeneca, a medicinal product for human use – Failure to comply with procedural requirements – Manifest inadmissibility.#Case T-265/25.

European Union · Court of Justice of the European Union · 27 February 2026

Record· TOCELEX 62025TO0156_INFdecided

Order of the General Court (Fourth Chamber) of 18 February 2026.#Accord Healthcare France SAS and Others v European Parliament and Council of the European Union.#Action for annulment – Environment – Treatment of urban waste water – Articles 1, 2, 9, 10, 30, Annexes I and III of Directive (EU) 2024/3019 – Extended liability of producers of medicinal products for human use and cosmetic products – Standing to act – Defect of individual assignment – ​​Inadmissibility.#Joined cases T-156/25, T-157/25, T-159/25 to T-168/25, T-170/25 and T-171/25.

European Union · Court of Justice of the European Union · 18 February 2026

Record· TOCELEX 62025TO0156decided

Order of the General Court (Fourth Chamber) of 18 February 2026.#Accord Healthcare France SAS and Others v European Parliament and Council of the European Union.#Actions for annulment – Environment – Urban wastewater treatment – Articles 1, 2, 9, 10 and 30 of, and Annexes I and III to, Directive (EU) 2024/3019 – Extended producer responsibility for medicinal products for human use and cosmetic products – Standing to bring proceedings – Lack of individual concern – Inadmissibility.#Joined Cases T-156/25, T-157/25, T-159/25 to T-168/25, T-170/25 and T-171/25.

European Union · Court of Justice of the European Union · 18 February 2026

Record· CJCELEX 62024CJ0379_SUMdecided

Judgment of the Court (Second Chamber) of 22 January 2026.#Agrupació de Neteja Sanitària, AIE and Educat Serveis Auxiliars SCCL v Tribunal Económico-Administrativo Regional de Cataluña (TEARC).#References for a preliminary ruling – Taxation – Common system of value added tax (VAT) – Directive 2006/112/EC – Supply of services by independent groups of persons, who are carrying on an activity which is exempt from VAT – Services directly necessary for the exercise of the exempt activity – Risk of distortion of competition – Cleaning services in the healthcare and education sectors – National legislation requiring that the services be directly and exclusively linked to the exempt activity and necessary for the exercise of that activity.#Joined Cases C-379/24 and C-380/24.

European Union · Court of Justice of the European Union · 22 January 2026

Record· CJCELEX 62024CJ0379decided

Judgment of the Court (Second Chamber) of 22 January 2026.#Agrupació de Neteja Sanitària, AIE and Educat Serveis Auxiliars SCCL v Tribunal Económico-Administrativo Regional de Cataluña (TEARC).#Requests for a preliminary ruling from the Tribunal Superior de Justicia de Cataluña.#References for a preliminary ruling – Taxation – Common system of value added tax (VAT) – Directive 2006/112/EC – Supply of services by independent groups of persons, who are carrying on an activity which is exempt from VAT – Services directly necessary for the exercise of the exempt activity – Risk of distortion of competition – Cleaning services in the healthcare and education sectors – National legislation requiring that the services be directly and exclusively linked to the exempt activity and necessary for the exercise of that activity.#Joined Cases C-379/24 and C-380/24.

European Union · Court of Justice of the European Union · 22 January 2026

Record· CJCELEX 62023CJ0731_SUMdecided

Judgment of the Court (Second Chamber) of 18 December 2025.#Nicoventures Trading Ltd and Others v European Commission.#Appeal – Public health – Heated tobacco products – Withdrawal of certain exemptions – Delegated Directive EU 2022/2100 – Action for annulment – Standing – Fourth paragraph of Article 263 TFEU – Condition that the applicant must be individually concerned by the contested act – Limited class of economic operators – Reporting and notification obligations – Marketing authorisation.#Case C-731/23 P.

European Union · Court of Justice of the European Union · 18 December 2025

Record· CJCELEX 62023CJ0731decided

Judgment of the Court (Second Chamber) of 18 December 2025.#Nicoventures Trading Ltd and Others v European Commission.#Appeal – Public health – Heated tobacco products – Withdrawal of certain exemptions – Delegated Directive (EU) 2022/2100 – Action for annulment – Standing – Fourth paragraph of Article 263 TFEU – Condition that the applicant must be individually concerned by the contested act – Limited class of economic operators – Reporting and notification obligations – Marketing authorisation.#Case C-731/23 P.

European Union · Court of Justice of the European Union · 18 December 2025

Record· TJCELEX 62023TJ0536_RESdecided

Judgment of the General Court (Sixth Chamber) of 3 December 2025.#AlzChem Trostberg GmbH v European Commission.#Public health – Biocidal products – Decision not approving cyanamide as an existing active substance for use in biocidal products of product-types 3 and 18 – Regulation (EU) No 528/2012 – Transitional measures – Manifest error of assessment – Proportionality.#Case T-536/23.

European Union · Court of Justice of the European Union · 3 December 2025

Record· TJCELEX 62023TJ0536decided

Judgment of the General Court (Sixth Chamber) of 3 December 2025.#AlzChem Trostberg GmbH v European Commission.#Public health – Biocidal products – Decision not approving cyanamide as an existing active substance for use in biocidal products of product-types 3 and 18 – Regulation (EU) No 528/2012 – Transitional measures – Manifest error of assessment – Proportionality.#Case T-536/23.

European Union · Court of Justice of the European Union · 3 December 2025

Report· CCCELEX 62024CC0118decided

Opinion of Advocate General Emiliou delivered on 23 October 2025.#EG Labo Laboratoires Eurogenerics SAS and Theramex France SAS v Agence nationale de sécurité du médicament et des produits de santé (ANSM) and Biogaran SAS.#Request for a preliminary ruling from the Conseil d'État.#Reference for a preliminary ruling – Directive 2001/83/EC – Medicinal products for human use – Articles 28 and 29 – Decentralised procedure for marketing authorisation for a medicinal product – Article 10 – Generic medicinal product – Abridged procedure for granting a marketing authorisation – Biological medicinal product serving as reference medicinal product for a chemical medicinal product – Jurisdiction of the courts of the Member States concerned to determine whether there is a potential serious risk for public health – Jurisdiction of those courts to review the conditions for granting a marketing authorisation for a generic medicinal product.#Case C-118/24.

European Union · Court of Justice of the European Union · 23 October 2025

Record· TJCELEX 62022TJ0483_RESdecided

Judgment of the General Court (Fifth Chamber, Extended Composition) of 24 September 2025.#Sanofi BV, anciennement Genzyme Europe BV v European Commission.#Public health – Medicinal products for human use – Marketing authorisation for the medicinal product Nexviadyme (avalglucosidase alfa) – Non-recognition of avalglucosidase alfa as a new active substance – Directive 2001/83/EC – Regulation (EC) No 726/2004 – Commission document ‘Notice to Applicants, Volume 2A, Procedures for marketing authorisation, Chapter 1, Marketing Authorisation’ – Standard of proof – Obligation to state reasons – Principle of good administration – Right to be heard – Decision to remove the medicinal product from the European Union Register of Orphan Medicinal Products – Regulation (EC) No 141/2000 – Regulation (EC) No 847/2000 – Significant benefit – Standard of proof – Obligation to state reasons.#Case T-483/22.

European Union · Court of Justice of the European Union · 24 September 2025

Record· TJCELEX 62024TJ0354_RESdecided

Judgment of the General Court (Sixth Chamber) of 24 September 2025.#Mowi Poland S.A. v European Commission.#Public health – Specific hygiene rules for food of animal origin – Regulation (EC) No 853/2004 – Point 3(e) of the Annex to Delegated Regulation (EU) 2024/1141 – Action for annulment – Locus standi – Interest in bringing proceedings – Admissibility – Concept of ‘frozen product’ – Lack of consultation with EFSA – Article 13 of Regulation No 853/2004.#Case T-354/24.

European Union · Court of Justice of the European Union · 24 September 2025

Record· TJCELEX 62024TJ0354decided

Judgment of the General Court (Sixth Chamber) of 24 September 2025.#Mowi Poland S.A. v European Commission.#Public health – Specific hygiene rules for food of animal origin – Regulation (EC) No 853/2004 – Point 3(e) of the Annex to Delegated Regulation (EU) 2024/1141 – Action for annulment – Locus standi – Interest in bringing proceedings – Admissibility – Concept of ‘frozen product’ – Lack of consultation with EFSA – Article 13 of Regulation No 853/2004.#Case T-354/24.

European Union · Court of Justice of the European Union · 24 September 2025

Record· TJCELEX 62022TJ0483decided

Judgment of the General Court (Fifth Chamber, Extended Composition) of 24 September 2025.#Sanofi BV, anciennement Genzyme Europe BV v European Commission.#Public health – Medicinal products for human use – Marketing authorisation for the medicinal product Nexviadyme (avalglucosidase alfa) – Non-recognition of avalglucosidase alfa as a new active substance – Directive 2001/83/EC – Regulation (EC) No 726/2004 – Commission document ‘Notice to Applicants, Volume 2A, Procedures for marketing authorisation, Chapter 1, Marketing Authorisation’ – Standard of proof – Obligation to state reasons – Principle of good administration – Right to be heard – Decision to remove the medicinal product from the European Union Register of Orphan Medicinal Products – Regulation (EC) No 141/2000 – Regulation (EC) No 847/2000 – Significant benefit – Standard of proof – Obligation to state reasons.#Case T-483/22.

European Union · Court of Justice of the European Union · 24 September 2025

Record· CJCELEX 62024CJ0115decided

Judgment of the Court (Fourth Chamber) of 11 September 2025.#UJ v Österreichische Zahnärztekammer.#Request for a preliminary ruling from the Oberster Gerichtshof.#Reference for a preliminary ruling – Public health – Cross-border healthcare – Directive 2011/24/EU – Article 3(d) and (e) – Provision of healthcare through telemedicine – Concept of ‘telemedicine’ – Cross-border healthcare provided through telemedicine – Complex medical treatment that includes healthcare provided in person and through telemedicine – Member State of treatment – Directive 2000/31/EC – Information society service – Directive 2005/36/EC – Professional qualifications – Freedom to provide services – Scope – Article 56 TFEU.#Case C-115/24.

European Union · Court of Justice of the European Union · 11 September 2025

Record· CJCELEX 62024CJ0115_RESdecided

Judgment of the Court (Fourth Chamber) of 11 September 2025.#UJ v Österreichische Zahnärztekammer.#Reference for a preliminary ruling – Public health – Cross-border healthcare – Directive 2011/24/EU – Article 3(d) and (e) – Provision of healthcare through telemedicine – Concept of ‘telemedicine’ – Cross-border healthcare provided through telemedicine – Complex medical treatment that includes healthcare provided in person and through telemedicine – Member State of treatment – Directive 2000/31/EC – Information society service – Directive 2005/36/EC – Professional qualifications – Freedom to provide services – Scope – Article 56 TFEU.#Case C-115/24.

European Union · Court of Justice of the European Union · 11 September 2025

Record· CJCELEX 62023CJ0489_RESdecided

Judgment of the Court (Fourth Chamber) of 4 September 2025.#AF v Guvernul României and Others.#Reference for a preliminary ruling – Social security – Health insurance – Article 56 TFEU – Freedom to provide services – Regulation (EC) No 883/2004 – Article 20(1) and (2) – Medical treatment received in a Member State other than the insured person’s Member State of residence – Directive 2011/24/EU – Article 7(7) – Assumption of the costs of treatment incurred by the insured person – Reimbursement – National legislation making reimbursement of those costs conditional upon the completion of a medical assessment, carried out exclusively by a health professional belonging to the public health insurance system of the insured person’s Member State of residence, which has given rise to the issuing, by that health professional, of a document authorising the hospitalisation of that insured person – Significant limitation of the reimbursement of the costs of cross-border healthcare.#Case C-489/23.

European Union · Court of Justice of the European Union · 4 September 2025

Record· CJCELEX 62023CJ0489decided

Judgment of the Court (Fourth Chamber) of 4 September 2025.#AF v Guvernul României and Others.#Request for a preliminary ruling from the Înalta Curte de Casaţie şi Justiţie.#Reference for a preliminary ruling – Social security – Health insurance – Article 56 TFEU – Freedom to provide services – Regulation (EC) No 883/2004 – Article 20(1) and (2) – Medical treatment received in a Member State other than the insured person’s Member State of residence – Directive 2011/24/EU – Article 7(7) – Assumption of the costs of treatment incurred by the insured person – Reimbursement – National legislation making reimbursement of those costs conditional upon the completion of a medical assessment, carried out exclusively by a health professional belonging to the public health insurance system of the insured person’s Member State of residence, which has given rise to the issuing, by that health professional, of a document authorising the hospitalisation of that insured person – Significant limitation of the reimbursement of the costs of cross-border healthcare.#Case C-489/23.

European Union · Court of Justice of the European Union · 4 September 2025

Record· TOCELEX 62024TO0223decided

Order of the General Court (Fourth Chamber) of 14 July 2025.#Pinpoint Innovations Ltd v European Commission.#Research and technological development – Horizon 2020 Framework Programme for Research and Innovation (2014-2020) – Development of a data analysis system to reduce delays in healthcare – Grant agreement – Actual recovery of a debt by the mutual insurance mechanism – Manifest lack of jurisdiction in part – Action in part manifestly inadmissible and in part manifestly lacking any foundation in law.#Case T-223/24.

European Union · Court of Justice of the European Union · 14 July 2025

Record· COCELEX 62024CO0139_INFdecided

Order of the Court (Seventh Chamber) of 3 July 2025.#UY v European Commission.#Appeal – Article 181 of the Rules of Procedure of the Court of Justice – Public health – Medicinal products for human use – Marketing authorisation – Comirnaty – COVID-19 vaccine – Action for annulment – Independence and impartiality of the Courts of the European Union – Interest in bringing proceedings – Locus standi – Fourth paragraph of Article 263 TFEU – Appeal in part manifestly inadmissible and in part manifestly unfounded.#Case C-139/24 P.

European Union · Court of Justice of the European Union · 3 July 2025

Record· COCELEX 62024CO0148_INFdecided

Order of the Court (Seventh Chamber) of 3 July 2025.#UY v European Commission.#Appeal – Article 181 of the Rules of Procedure of the Court of Justice – Public health – Medicinal products for human use – Marketing authorisation – Spikevax – COVID-19 vaccine – Action for annulment – Independence and impartiality of the Courts of the European Union – Interest in bringing proceedings – Locus standi – Fourth paragraph of Article 263 TFEU – Appeal in part manifestly inadmissible and in part manifestly unfounded.#Case C-148/24 P.

European Union · Court of Justice of the European Union · 3 July 2025

Record· COCELEX 62024CO0148decided

Order of the Court (Seventh Chamber) of 3 July 2025.#UY v European Commission.#Appeal – Article 181 of the Rules of Procedure of the Court of Justice – Public health – Medicinal products for human use – Marketing authorisation – Spikevax – COVID-19 vaccine – Action for annulment – Independence and impartiality of the Courts of the European Union – Interest in bringing proceedings – Locus standi – Fourth paragraph of Article 263 TFEU – Appeal in part manifestly inadmissible and in part manifestly unfounded.#Case C-148/24 P.

European Union · Court of Justice of the European Union · 3 July 2025

Record· COCELEX 62024CO0139decided

Order of the Court (Seventh Chamber) of 3 July 2025.#UY v European Commission.#Appeal – Article 181 of the Rules of Procedure of the Court of Justice – Public health – Medicinal products for human use – Marketing authorisation – Comirnaty – COVID-19 vaccine – Action for annulment – Independence and impartiality of the Courts of the European Union – Interest in bringing proceedings – Locus standi – Fourth paragraph of Article 263 TFEU – Appeal in part manifestly inadmissible and in part manifestly unfounded.#Case C-139/24 P.

European Union · Court of Justice of the European Union · 3 July 2025

Page 1 of 2Next